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It	has	been	thirty	years	since	the	first	genetically	engineered	animal	with	altered	milk	composition	
was	 reported.	 During	 the	 intervening	 years,	 the	world	 population	 has	 increased	 from	 5bn	 to	 7bn	
people.	An	increasing	demand	for	protein	in	the	human	diet	has	followed	this	population	expansion,	
putting	huge	stress	on	the	food	supply	chain.	Many	solutions	to	the	grand	challenge	of	food	security	
for	all	have	been	proposed	and	are	currently	under	investigation	and	study.	Amongst	these,	genetics	
still	 has	 an	 important	 role	 to	 play,	 aiming	 to	 continually	 enable	 the	 selection	 of	 livestock	 with	
enhanced	 traits.	 Part	 of	 the	 geneticist’s	 tool	 box	 is	 the	 technology	 of	 genetic	 engineering.	 In	 this	
review	 article,	 we	 indicate	 that	 this	 technology	 has	 come	 a	 long	 way,	 we	 focus	 on	 the	 genetic	
engineering	of	dairy	animals	and	we	argue	 that	 the	new	strategies	 for	precision	breeding	demand	
proper	 evaluation	 as	 to	 how	 they	 could	 contribute	 to	 the	 essential	 increases	 in	 agricultural	
productivity	our	society	must	achieve.		
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What	is	milk	
Milk	 is	 part	 of	 the	 definition	 of	what	 a	mammal	 is.	 It	 is	 one	 of	 the	major	 protein	 sources	 on	 the	
planet.	Seen	from	the	perspective	of	the	mammalian	neonate,	milk	 is	the	fuel	required	for	growth	
and	survival.	This	 in	 itself	 is	enough	to	make	milk	perhaps	the	most	 important	food	on	the	planet,	
but	milk	is	more	than	just	something,	albeit	a	very	important	something,	that	neonates	must	have.	
For	 the	 dairy	 farmer,	 it	 is	 his	 primary	 product	 ensuring	 his	 livelihood,	 while	 the	 food	 producer	
recognises	 its	 chemical	 properties	 as	 the	 basis	 for	 a	 wide	 range	 of	 commercially	 valuable	 food	
products.		
Milk	 as	 a	 commercial	 food	 product	 is	 produced	 all	 around	 the	world	with	 one-third	 of	 the	 global	
production	residing	 in	 India,	USA	and	China.	There	 is	no	country	 that	does	not	have	milk	and	milk	
products	 as	 part	 of	 their	 economy.	 For	 some	 countries,	 for	 example	 New	 Zealand,	 it	 is	 a	 major	
component	of	 the	annual	 commodities	exports.	We	benefit	 from	a	number	of	domesticated	dairy	
species	–	cow,	buffalo,	goat,	sheep	camel	and	yak	–	with	cow’s	milk	alone	amounting	to	over	700m	
tonnes	in	2013	with	more	than	6bn	people	consuming	dairy	products	(FAO,	2013).	
Although	milk	is	the	result	of	evolution	over	considerable	periods	of	time,	one	can	still	ask	whether	
commercially	available	milks	and	milk	products	are	optimal	for	current	societal	needs.	Many	around	
the	world	cannot	consume	milk	or	dairy	products	due	to	allergies	or	lactose	intolerance.	Dairy	herds	
in	the	diverse	geographical	regions	of	the	world	show	huge	differences	in	milk	production	volumes.	
In	 highly	 productive	 dairy	 herds,	 we	 are	 challenged	 to	 achieve	 simultaneous	 genetic	 gain	 in	milk	
production	 and	 reproductive	 performance	 while	 optimising	 animal	 healthreducing	 the	 impact	 of	
disease	and	enhancing	welfare	standards.	If	the	range	of	proteins	found	in	milk	could	be	expanded,	
alternative	uses	of	milk	could	be	envisaged.	There	are	many	ways	in	which	milk	could	be	enhanced.	
We	describe	one	route	to	achieve	this	goal,	that	of	using	genetic	engineering	technology.	We	focus	
on	the	mammary	gland	and	milk,	and	hence	food	security,	whilst	being	aware	that	manipulations	of	
other	 aspects	of	 the	physiology	and	pathophysiology	of	 the	 lactating	animal	 could	have	beneficial	
impacts	on	its	health	and	welfare.			
Milk	has	been	a	target	for	the	genetic	engineer	since	the	emergence	of	this	technology	30	years	ago	
(Simons	et	al.,	1987).	From	the	early	days	of	 this	 research	field,	 the	majority	of	effort	has	been	to	
develop	 livestock	as	animal	bioreactors	of	biomedical	proteins	 (Clark	 et	al.,	1989).	This	goal	 is	 still	
actively	pursued	and	has	been	the	focus	of	numerous	reviews	(Wilmut	&	Whitelaw,	1994;	Lubon	et	
al.,	1996;	Houdebine,	2000;	Kind	&	Schnieke,	2008;Cooper	et	al.,	2015)	 .	Given	the	advent	of	new	
tools	 to	engineer	 the	genome	of	 livestock	we	believe	 the	opportunity	 to	engineer	milk	proteins	 is	
likely	to	re-emerge.		
	
Brief	history	of	GM	milk	
The	 first	 genetically	 engineered	 mammals	 were	 produced	 at	 the	 end	 of	 the	 1970s	 (Palmiter	 &	
Brinster,	1986).	Those	working	in	large	animal	biology	quickly	saw	the	potential	for	agriculture	and	
embarked	 on	 two	 complementary	 avenues	 of	 research.	 The	 first	 attempted	 to	 modify	 growth	
through	 growth	 hormone-encoding	 transgenes.	 Although	 extremely	 useful	 in	 fuelling	 the	 early	
progress	of	the	field,	and	providing	for	much	ethical	debate,	this	research	direction	was	not	initially	
successful,	with	the	‘Beltsville’	pigs	displaying	a	range	of	undesirable	phenotypes	(Pursel	et	al.,	1989;	
1990).	 Some	 have	 sustained	 research	 activity	 in	 this	 area	 of	 research,	 with	 minor	 successes	 in	
changing	back	fat	being	achieved	along	the	way	(Pursel	et	al.,	2004).	Recently,	 the	goal	of	altering	
meat	composition	has	seen	a	resurgence	of	activity,	largely	revolving	around	the	myostatin	gene	(or	
growth	 derived	 factor	 8)	with	 a	 number	 of	 groups	 around	 the	world	 actively	 engaged	 in	 projects	
aiming	to	alter	farm	livestock	muscle	growth	(Crispo	et	al.,	2015;	Proudfoot	et	al.,	2015;	Qian	et	al.,	
2015)		
The	alternative	strategy,	that	of	modifying	milk	composition,	kick	started	with	mice	that	expressed	
the	whey	protein	β-lactoglobulin	(Simons	et	al.,	1987).	Mice	do	not	normally	produce	this	protein.	
This	 study	 definitely	 demonstrated	 that	 substantial	 changes	 to	 milk	 composition	 could	 be	
engineered	without	 causing	 deleterious	 phenotypic	 effects.	 This	was	 a	 pointer	 for	what	 is	 still	 an	
active	area	of	 academic	 research	which	has	also	progressed	 to	 the	 commercial	 sector	 and	human	
clinic:	farm	livestock	could	be	used	as	‘bioreactors’	for	desirable	biomedical	proteins.	Using	the	gene	
promoters	 from	 various	milk	 protein	 genes,	 a	 number	 of	 human	proteins	 have	 been	made	 in	 the	
mammary	gland	of	transgenic	livestock.	Much	has	been	done	to	optimise	harvest	and	purification	of	
these	proteins	e.g.	(Zhao	et	al.,	2015),	with	the	first	to	successfully	navigate	through	the	appropriate	
regulatory	 process	 and	 reach	 the	 clinic	 in	 2006	 (Pollock	 et	 al.,	 1999;	 2009).	 In	 parallel,	 a	 diverse	
range	of	transgene	designs	were	evaluated	providing	valuable	information	for	the	entire	transgenic	
community.		
The	research	activity	 involved	in	progressing	farm	livestock	as	animal	bioreactors	of	proteins	had	a	
profound	impact	on	the	field	of	genetically	engineered	livestock.	This	was	initially	achieved	through	
the	use	of	pronuclear	injection	technology	which	involved	the	direct	injection	of	the	transgene	DNA	
into	the	zygote	(Hammer	et	al.,	1985).	This	method	enables	transgenes	to	be	added	to	the	genome.	
Pronuclear	injection	is	a	robust	but	inefficient	method,	this	inefficiency	being	a	major	driver	for	the	
development	of	somatic	cell	nuclear	transfer	or	cloning	technology,	made	famous	through	the	birth	
of	Dolly	20	years	ago.	Cloning	technology	changed	how	the	genetic	engineer	planned	their	project.	
Genes	could	now	be	 inserted	 into	 the	gene	at	a	given	 location	 rather	 than	 relying	on	 the	 random	
integration	associated	with	zygote	injections	(Schnieke	et	al.,	1997).	For	the	first	time	in	livestock,	in	
addition	to	gene	addition,	genes	could	be	destroyed	(knock-out	animals)	to	generate	null	alleles.	In	
addition,	new	transgene	designs	became	available	that	could	result	in	reduction	(knockdown)	of	the	
transgene	activity,	for	example	those	based	on	RNAi	(Clark	&	Whitelaw,	2003).	
In	 the	 first	decade	of	experimentally	modifying	milk	 through	genetic	engineering	 strategies,	genes	
were	 added	 to	 the	 genome.	 Outside	 of	 purely	 academic	 research	 projects,	 most	 were	 hoping	 to	
result	 in	 a	 commercial	 product	 destined	 for	 the	 human	 clinic.	 There	 was	 ‘talk’	 of	 altering	 milk	
composition	 for	animal	nutrition	and	 food	processing	goals	but	very	 little	activity	 in	 this	direction.	
With	the	development	of	new	transgene	designs	a	number	of	milk	modifications	were	tested	over	
the	following	two	decades.	
Elevated	protein	levels.	Milk	is	rich	in	proteins.	Although	there	are	a	number	of	proteins	in	milk,	the	
majority	are	termed	either	casein	or	whey.	Caseins	are	the	dominant	milk	protein	family,	with	most	
species	expressing	at	least	three	different	casein	proteins.	Cattle	milk	contains	the	calcium	sensitive	
α-	and	β-casein	in	addition	to	κ-casein,	the	latter	being	common	to	all	mammalian	milk	and	involved	
in	casein	micelle	formation	and	size.	In	addition	to	simply	increasing	the	protein	content	in	the	milk,	
naturally	 elevated	 levels	 of	 β-	 and	 κ-casein	 have	 been	 linked	 to	 improved	 heat	 stability	 and	
processing	properties	of	milk.	In	New	Zealand,	the	AgResearch	team	led	by	Goetz	Laible	engineered	
cattle	to	have	extra	copies	of	bovine	β-	and	κ-casein	genes.	These	animals	had	17-35%	more	total	
milk	casein,	with	β-	and	κ-casein	content	nearly	doubled	compared	to	non-transgenic	cattle	(Brophy	
et	al.,	2003).			
Animals	over-expressing	whey	proteins	have	also	been	produced.	 In	an	early	 study	at	Beltsville	by	
Bob	Wall	and	colleagues,	transgenic	pigs	were	produced	that	over-expressed	the	mouse	whey	acidic	
protein.	Although	successful	in	expressing	levels	of	the	mouse	protein	in	pig	milk	approaching	those	
found	in	mouse	milk,	some	transgenic	pigs	were	unable	to	sustain	lactation	(Wall	et	al.,	1991).	The	
physiological	 reason	 for	 this	 was	 not	 determined.	 Subsequently,	 Matt	 Wheeler	 and	 colleagues	
produced	 transgenic	 pigs	 engineered	 to	 express	 a	 bovine	 α-lactalbumin	 transgene	 (Bleck	 et	 al.,	
1998).	 With	 initial	 concentrations	 of	 nearly	 1mg/ml,	 bovine	 α-lactalbumin	 levels	 were	 found	 to	
decrease	as	lactation	proceeded	in	these	pigs.	These	animals	carried	a	transgene	based	on	genomic	
bovine	α-lactalbumin	sequences	and	species	differences	in	transcriptional	control	were	proposed	to	
account	for	the	fold	shift	in	bovine	to	porcine	α-lactalbumin	ratio	from	4.3:1	at	the	start	of	lactation	
to	 0.43:1	 by	 day	 20	 of	 lactation.	 These	 animals	 displayed	 elevated	 lactose	 levels	 and	 great	 milk	
production	 volumes.	 Litters	 reared	 by	 transgenic	 gilts	 grew	 faster	 and	 were	 heavier	 than	 those	
suckling	on	control	gilts	(Noble	et	al.,	2002;	Marshall	et	al.,	2006)	and	evaluation	of	this	strategy	to	
combat	neonatal	losses	in	the	pig	industry	is	continuing.	
In	the	casein	over-expressing	cattle,	animals	with	the	highest	level	of	casein	also	displayed	a	slightly	
lower	 total	 milk	 protein	 amount	 (Brophy	 et	 al.,	 2003),	 reminiscent	 of	 earlier	 mouse	 work	 where	
over-expression	 of	 β-lactoglobulin	 in	 some	 animals	 corresponded	 with	 reduced	 casein	 levels	
reflecting	what	appeared	to	be	a	ceiling	on	total	milk	production,	at	least	in	some	lines	of	transgenic	
mouse	(McClenaghan	et	al.,	1995).	The	effect	of	a	ceiling	for	protein	production	remains	to	be	fully	
understood	and	could	have	bearing	on	replacement	and	bioreactor	strategies.		
Another	 project	 started	 some	 years	 ago	 but	 now	 seeing	 rewarding	 progress	 relates	 to	 over-
expression	 of	 a	 human	 lysozyme	 transgene	 in	 goats.	 Lysozyme	 possesses	 both	 antimicrobial	
properties	and	the	ability	to	modulate	the	inflammation	response.	The	groups	of	Elizabeth	Maga	and	
Jim	Murray	were	able	to	produce	transgenic	lysozyme	animals	whose	overall	milk	composition	was	
not	 altered	beyond	 the	presence	of	 human	 lysozyme	 to	 a	 level	 approaching	 that	 found	 in	human	
milk	(Maga	et	al.,	2006).	The	milk	did	have	altered	properties	reflected	in	a	shorter	rennet	clotting	
time	and	increased	curd	strength	which	could	be	of	benefit	to	the	milk	processing	industry.	Another	
pointer	 to	what	 is	 possible	 through	 engineering	milk.	More	 recent	 data	 from	 this	 UC	 Davis	 team	
demonstrated	 that	 consumption	of	 the	 lysozyme-rich	milk	 improved	 intestinal	 and	 systemic	piglet	
health	 (Cooper	 et	 al.,	 2014).	 Similar	 positive	 impacts	 on	 neonatal	 health	 were	 demonstrated	 for	
transgenic	 cow	 milk	 containing	 human	 lactoferrin,	 while	 earlier	 work	 indicated	 that	 cow’s	 milk	
containing	 the	bacterial	enzyme	 lysostaphin	 resulted	 in	 reduced	mastitis	 in	 the	 transgenic	animals	
(Wall	 et	 al.,	 2005).	 These	 studies	 clearly	 demonstrate	 benefits	 to	 neonatal	 livestock	 health.	 In	
addition,	Caitlin	Cooper	in	the	UC	Davis	team	reported	that	consumption	of	the	lysozyme-rich	milk	
helped	 to	 resolve	 diarrhoea	 in	 piglets,	 suggesting	 that	 similar	 benefits	 to	 human	 health	 through	
effective	 treatment	 of	 Escherichia	 coli	 induced	 diarrhoea	were	 likely	 (Cooper	 et	 al.,	 2013).	 In	 the	
future	we	 can	 anticipate	 disease	mitigation	 being	 a	major	 target	 for	 both	 precision	 breeding	 and	
agriculture	in	general.		
A	 number	 of	 other	 transgenic	 studies	 aiming	 to	 genetically	 engineer	 milk	 have	 been	 reported,	
ranging	from	reducing	the	levels	of	lactose	in	the	milk	of	mice	(Jost	et	al.,	1999;	Whitelaw,	1999)	to	
altering	 fat	composition	by	a	stearoyl-coA	desaturase	transgene	 in	goats	 (Reh	et	al.,	2004).	All	 the	
above	 studies	 relied	 on	 transgenic	 approaches	 that	 led	 to	 over-expression	 of	 milk	 protein	 or	
production	of	a	novel	protein	in	the	mammary	gland.	Transgenic	technology	also	enables	reduction	
or	generation	of	null-alleles	and	such	approaches	have	seen	success.		
RNAi	studies	in	the	mammary	gland.	A	powerful	genetic	tool	relies	on	RNA	mediated	destruction	of	
target	messenger	RNAs	(those	that	encode	proteins).	This	has	proved	a	valuable	approach	to	alter	
gene	 activity	 in	 plants	 but	 has	 proven	 fickle	 in	 animals	 –	 with	 one	 spectacular	 success.	 The	
AgResearch	team	led	by	Goetz	Laible	demonstrated	that	transgenes	evoking	RNA	interference	could	
have	 profound	 effects	 on	 milk	 composition	 (Jabed	 et	 al.,	 2012).	 They	 designed	 a	 microRNA	 that	
targeted	both	ovine	and	bovine	β-lactoglobulin.	Initially	they	showed	that	this	microRNA	transgene	
resulted	 in	 knockdown	 of	 ovine	 β-lactoglobulin	 in	 transgenic	 mice	 expressing	 this	 sheep	 protein.	
Subsequently,	 they	 produced	 cattle	 transgenic	 for	 the	microRNA,	 the	milk	 from	which	 had	 barely	
detectable	 levels	 of	β-lactoglobulin.	 The	 animals	 appear	 to	 have	 ‘compensated’	 for	 this	 lack	 of	 a	
whey	milk	protein	since	they	had	elevated	levels	of	the	other	major	milk	proteins.	 In	particular,	α-	
and	 β-casein	 were	 elevated	 two-fold,	 κ-casein	 four-fold	 and	 α-lactalbumin	 two-fold	 higher.	 This	
achievement	 is	 especially	 notable	 given	 the	 very	 high	 levels	 of	 β-lactoglobulin	 mRNA	 present	 in	
mammary	epithelial	cells.	
What	 is	 very	 noticeable	 about	 all	 of	 the	 above	 projects,	 even	 those	 clearly	 demonstrating	 animal	
health	benefits,	 is	 the	 lack	of	progression	 into	 the	 commercial	 sector.	Many	hope	 that	 it	 is	only	a	
matter	of	time	for	this	progression	to	occur	(Murray	&	Maga,	2010).	
Gene	 knock-out.	 All	 the	 above	 studies	 revolved	 around	 transgene	 addition	 strategies,	 be	 it	 a	
genomic	 gene	 fragment,	 cDNA-based	 transgene	 or	 one	 exploiting	 a	 RNA	 interference	 strategy.	
Although	somatic	 cell	nuclear	 transfer	 could	enable	 transgenic	gene	knock-outs	 (to	produce	a	null	
allele),	something	which	was	achieved	in	biomedical	orientated	livestock	projects,	this	approach	was	
not	 pursued	 to	 engineer	milk	 composition.	However,	 such	 studies	were	 successfully	 performed	 in	
mouse	models.	
The	first	milk	protein	gene	to	be	knocked-out	was	achieved	by	Satish	Kumar,	who	was	then	at	the	
Roslin	 Institute	 (Kumar	 et	 al.,	 1994).	 Mice	 lacking	 β-casein	 were	 generated	 by	 gene	 targeting	 in	
mouse	embryonic	stem	cells	and	produced	milk	with	reduced	micelle	size.	The	reduction	in	overall	
casein	levels	due	to	the	absence	of	β-casein	protein	was	associated	with	a	corresponding	increase	in	
the	whey	proteins.	These	changes	 to	milk	composition	and	physical	 formation	resulted	 in	 reduced	
growth	of	suckled	pups.	No	other	obvious	phenotypic	effect	on	the	pups	was	observed.		
In	a	similar	way,	mice	lacking	α-casein	have	been	produced	by	Andreas	Kolb	working	with	colleagues	
at	 the	 Roslin	 Institute	 (Kolb	 et	 al.,	 2011).	 Analysis	 of	 milk	 from	 these	 animals	 indicated	 that	 in	
addition	to	a	 lack	of	α-casein,	 levels	of	the	remaining	caseins	and	the	whey	acidic	protein	were	all	
reduced,	 indicating	 that	 the	 absence	 of	 α-casein	 affects	 the	 secretion	 of	 all	 other	 milk	 proteins	
expressed	 in	mammary	epithelial	cells.	Although	up-regulation	of	grp78,	grp94	and	PDIA6	proteins	
pointed	 towards	 involvement	of	 endoplasmic	 reticulum	 stress,	 no	morphological	 differences	were	
observed.	The	reduced	milk	protein	levels	had	an	impact	on	the	suckling	young,	resulting	in	reduced	
body	 weight	 though	 out	 life.	 This	 team	 subsequently	 demonstrated	 through	 pup	 cross	 fostering	
studies	that	non-transgenic	pups	suckled	by	α-casein	deficient	dams	showed	delayed	development	
and	reduced	body	weight	as	compare	to	wild	type	mice	upon	maturity	(Huber	et	al.,	2013).	Thus,	as	
with	β-casein	 null	milk,	 neonates	 suckled	with	α-casein	 null	milk	 failed	 to	 gain	 full	 body	 size	 but	
otherwise	developed	normally.	
Even	more	dramatic	effects	were	produced	by	knocking-out	κ-casein	from	mouse	milk.	This	calcium	
insensitive	 phosphoglycoprotein	 is	 present	 in	 the	 milk	 of	 all	 mammals	 including	 the	 marsupials.	
Work	by	Satish	Kumar,	now	at	CCMB	in	Hyderabad,	won	the	race	to	produce	κ-casein	gene	knock-
out	mice	(Shekar	et	al.,	2006).	These	animals	did	not	produce	any	κ-casein	in	their	mammary	gland,	
with	 expression	 of	 the	 other	 casein	 genes	 remaining	 unaffected,	 and	 κ-casein	 null	 females	 were	
viable,	fertile	and	carried	pregnancy	to	term.	However,	females	were	unable	to	let	down	milk	even	
after	oxytocin	 injections.	Although	milk	was	produced	within	 the	mammary	gland,	 it	coagulated	 in	
situ	 and	 was	 retained	 (blocking)	 in	 the	 gland	 lumina.	 A	 similar	 outcome,	 the	 inability	 to	 sustain	
offspring	through	suckling,	was	observed	for	α-lactalbumin	knock-out	mice	(Stacey	et	al.,	1995).	
	
The	new	genome	editing	tools		
We	 are	 entering	 a	 new	 era	 for	modifying	milk	 by	 genetic	 engineering	 approaches.	 An	 era	where	
there	is	the	real	likelihood	that	multiple	genetically	engineered	livestock	projects	will	progress	from	
the	 laboratory	 to	 the	 farm	 and	 thus	 into	 our	 food	 chain.	 The	 goals	 haven’t	 changed;	 to	 produce	
more	 milk	 whilst	 simultaneously	 optimising	 animal	 health,	 to	 produce	 more	 appropriate	 milk	
products,	 and	 to	 establish	 alternative	 dairy	 usage.	 This	 renewed	 enthusiasm	 is	 based	 on	 new	
technology,	with	 the	advent	of	 the	genome	editors	now	enabling	efficient	and	precise	 changes	 to	
the	genomes	of	livestock	(Fahrenkrug	et	al.,	2010).	For	example,	DNA	deletions	or	insertions,	or	DNA	
base	 exchanges	 can	 be	 achieved,	 and	 in	 this	 way	 alleles	 can	 be	 made	 or	 removed	 from	 a	 given	
population	(Tan	et	al.,	2013).		
What	are	genome	editors?		
At	their	simplest,	genome	editors	are	precision	tools	that	can	be	used	to	target	a	specific	location	in	
the	DNA	of	a	cell,	creating	a	break	in	the	DNA	at	that	position.	To	put	this	into	context,	the	bovine	
genome	is	approximately	3	billion	bases	long;	targeting	a	specific	location	in	this	genome	is	akin	to	
locating	a	single	 letter	 from	a	stack	of	over	800	King	 James	bibles.	There	are	currently	 three	main	
types	 of	 genome	 editor,	 and	 each	 works	 in	 a	 slightly	 different	 way.	 Zinc	 fingers	 are	 naturally	
occurring	small	protein	motifs,	many	of	which	have	DNA	binding	functions.	The	Cys2His2	zinc	fingers	
currently	used	bind	three	specific	DNA	bases,	and	can	be	organised	into	arrays	that	recognise	larger	
stretches	of	DNA.	These	zinc	finger	arrays	are	in	turn	fused	to	the	nuclease	domain	of	the	obligate	
dimer	FokI,	a	restriction	endonuclease,	forming	a	zinc-finger	nuclease	(ZFN).	ZFNs	are	employed	as	
pairs	that	between	them	recognise	between	18	and	32	bases	of	DNA,	with	each	member	of	the	pair	
binding	one	or	other	strand	of	 the	DNA	double	helix.	Binding	of	a	pair	of	ZFNs	to	their	designated	
target	site	results	in	the	2	halves	of	the	FokI	dimerising	on	the	intervening	sequence	and	cutting	the	
DNA.	ZFNs	have	been	used	 to	aid	 in	modification	of	 the	bovine	genome	 (Liu	 et	al.,	 2014b),	but	 in	
general	 their	 uptake	 by	 the	 livestock	 research	 community	 has	 been	 relatively	 low,	 limited	 by	
complexities	in	their	design.	
Transcription	 activator-like	 effectors	 (TALEs)	 are	 proteins	 used	 by	 proteobacteria	 of	 the	 genus	
Xanthomonas	to	subvert	the	transcriptional	activity	 in	the	cells	of	their	plant	hosts.	These	proteins	
are	composed	of	an	array	of	DNA-binding	modules,	with	each	module	having	specificity	for	binding	a	
single	DNA	base.	Scientists	have	utilised	this	1-to-1	relationship	between	protein	modules	and	DNA	
bases	to	build	their	own	protein	arrays	capable	of	binding	almost	any	sequence	within	the	genome.	
As	with	ZFNs,	the	TALE	array	is	fused	to	the	FokI	nuclease	to	give	a	TALEN,	and	as	with	ZFNs	these	
are	employed	in	pairs	to	allow	dimerization	of	FokI	to	give	targeted	cutting.	TALENS	have	been	more	
widely	 utilised	 in	 livestock	 research	 than	 ZFNs,	 largely	 due	 to	 their	 relative	 ease	 of	 design	 and	
synthesis	(Tan	et	al.,	2013;	Proudfoot	et	al.,	2015;	Wu	et	al.,	2015).	
The	 CRISPR/Cas	 system	 utilised	 by	 scientists	 has	 been	 derived	 from	 a	 bacterial	 innate	 immune	
system	 that	 allows	 the	 bacteria	 to	 rapidly	 respond	 to	 previously-encountered	 pathogens	 such	 as	
bacteriophage	 or	 plasmids.	 This	 genome	 editing	 tool	 has	 significant	mechanistic	 differences	 from	
both	TALENs	and	ZFNs;	while	both	of	the	aforementioned	tools	use	protein	DNA-binding	motifs	to	
guide	a	fused	nuclease	to	the	target	site,	the	CRISPR/Cas	system	utilises	Watson-Crick	base	pairing	
between	a	 short	guide	RNA	 (20	nucleotides	 in	 length)	and	 its	 cognate	 target	 sequence	 to	direct	a	
complexed	nuclease	(currently	most	typically	the	Cas9	nuclease)	to	cut	at	the	said	site.	CRISPR/Cas	is	
arguably	the	simplest	of	the	genome	editor	systems	to	use,	and	as	such	has	seen	a	very	rapid	uptake	
by	 the	 research	community	 since	 the	 seminal	publications	by	both	 the	Zhang	and	 Jaenisch	 labs	 in	
early	2013	(Cong	et	al.,	2013;	Yang	et	al.,	2013).	
Cellular	repair	of	the	breaks	introduced	by	genome	editors	is	predominantly	by	the	non-homologous	
end	joining	(NHEJ)	pathway,	widely	considered	to	be	error	prone,	the	consequence	of	which	is	the	
introduction	of	small	 insertions	or	deletions	(indels)	at	the	cut	site;	 if	 that	site	 is	within	the	coding	
sequence	 of	 a	 gene	 then	 the	 outcomes	 range	 from	 insertion,	 deletion	 or	 modification	 of	 single	
amino	 acids	 (the	 building	 blocks	 of	 proteins)	 to	 frameshift	 events	 and	 functional	 gene	 knockout.	
Refinement	 of	 editor	 application	 to	 include	 a	 DNA	 template	 molecule	 can	 result	 in	 the	 cell	
performing	homology-directed	 repair	 rather	 than	NHEJ,	meaning	 that	 specific	 rather	 than	 random	
changes	can	be	introduced.	These	can	take	the	form	of	anything	from	single	base	changes	to	allele	
exchange.	 Alternatively,	 editors	 can	 be	 applied	 in	 pairs	 to	 effectively	 delete	 the	 chosen	 sequence	
between	them	from	the	genome.	This	allows	researchers	to	remove	either	entire	genes	or	specific	
portions	of	a	gene.	
With	 regard	 to	milk	production,	 this	new	genetic	 technology,	based	on	 the	genome	editors	which	
enable	 precision	 breeding,	 can	 be	 applied	 to	 all	 dairy	 species.	 It	 has	 been	 achieved	 in	 cattle	
(Proudfoot	et	al.,	2015),	sheep	(Proudfoot	et	al.,	2015;	Crispo	et	al.,	2015)	and	goats	(Ni	et	al.,	2014);	
it	can	only	be	a	matter	of	time	before	genome	edited	buffalo	are	produced.	
	
What	could	be	done	–	the	opportunities	
There	are	a	variety	of	ways	genome	editing	technology	can	be	used	 in	regard	to	engineering	milk.	
First,	 if	 desired,	 all	 the	 studies	 in	 mice	 utilising	 transgenic	 gene	 knockout	 strategies	 could	 be	
repeated	 using	 the	 genome	 editors.	 Except	 in	 this	 way	 the	 animals	 would	 not	 be	 transgenic	 but	
merely	 carry	 a	 specific	 mutation	 at	 a	 precise	 site	 within	 the	 target	 gene	 which	 results	 in	 gene	
inactivation.	This	could	be	achieved	through	the	production	of	a	NHEJ	enabled	frame-shift	mutation	
causing	an	otherwise	out-of-frame	stop	codon	to	be	 translated.	This	can	be	efficiently	achieved	 in	
livestock	as	demonstrated	by	Simon	Lillico	and	colleagues	 for	 the	porcine	RELA	gene	 (Lillico	 et	al.,	
2013).	 An	 alternatively	 strategy	 could	 be	 to	 delete	 the	 transcriptional	 start	 site	 and/or	 the	
translational	AUG	codon,	thus	inactivating	the	target	gene.	
The	gene	knock-out	mouse	studies	indicate	that	the	calcium	sensitive	caseins	could	be	removed,	at	
least	 individually,	 and	 lactation	maintained.	However,	 in	 these	 animals	 pup	 growth	was	 impaired,	
although	the	smaller	resultant	animals	were	otherwise	normal	 in	development	and	behaviour.	 It	 is	
possible	 that	 reduced	 milk	 protein	 levels	 achieved	 through	 a	 NHEJ	 indel	 mutation	 could	 be	
complemented	by	the	coincident	insertion	of	a	transgene,	thus	engineering	the	production	of	other	
proteins	 (including	 other	 milk	 proteins)	 to	 bring	 total	 proteins	 levels	 back	 to	 normal	 levels.	
Dependent	on	the	actual	protein,	this	should	be	able	to	maintain	both	normal	lactation	and	offspring	
growth.		
Potentially	more	powerful,	HDR	can	be	evoked	to	engineer	more	subtle	and	predetermined	changes	
to	the	genome.	Through	supply	of	the	appropriate	template	DNA	with	the	genome	editor,	HDR	can	
be	used	 to	 produce	different	 alleles,	 even	 entire	 haplotypes.	 This	 has	 been	 achieved	 in	 pigs	 for	 a	
candidate	 gene	 involved	 in	 host	 resilience	 to	 a	 virus	 (Lillico	 et	 al,	 in	 press).	 Goetz	 Laible,	 Scott	
Fahrenkrug	and	colleagues	have	indicated	how	this	could	be	used	to	engineer	milk.	Building	on	their	
success	with	 an	 RNAi	 transgene	 to	 knock-down	β-lactoglobulin	 activity,	 this	 group	 used	 both	 ZFN	
and	TALEN	reagents	to	inactivate	the	bovine	β-lactoglobulin	gene	through	an	HDR	event	(Wei	et	al.,	
2015).	Although	 this	project	has	 still	 to	progress	 to	 testing	 in	 animals,	 it	 clearly	points	 the	way	 to	
inactivating	 any	of	 the	milk	protein	 genes	 in	 livestock.	Given	 that	β-lactoglobulin	 is	 considered	an	
allergen,	producing	cattle	milk	which	lacked	this	protein	could	considerably	increase	the	use	of	this	
animal	 product	 as	 a	 substitute	 for	 human	milk.	 It	 is	 estimated	 that	 2-3%	of	 infants	 are	 allergic	 to	
cow’s	milk	during	the	first	year	of	their	 life.	This	study	 indicates	that	 it	should	be	easy	to	engineer	
milk	by	exchange	of	alleles	associated	with	different	milk	properties	or	alleles	associated	with	great	
milk	production	potential.	There	is	also	the	possibility	of	engineering	milk	protein	genes	to	optimise	
availability	 of	 bioactive	 peptides	 released	 during	 digestion	 in	 the	 gut	 (Nongonierma	&	 FitzGerald,	
2015).	 This	 could	 be	 through	 capturing	 genetic	 variation	 in	 the	 milk	 protein	 genes	 (Caroli	 et	 al.,	
2009),	 including	 that	 variation	 underlying	 the	 unique	 antimicrobial	 properties	 of	 monotremes	
(Enjapoori	et	al.,	2014).	An	intriguing	extension	to	this	line	of	thought	would	be	engineering	vaccines	
into	milk,	 the	 feasibility	of	which	has	been	demonstrated	 through	 the	production	of	 antibodies	 in	
transgenic	milk	 (Sola	et	al.,	1998;	Kolb	et	al.,	2001).	Further,	allelic	variation	which	confers	altered	
physical	 properties	 and	 thus	 facilitates	 the	 processing	 of	 milk	 into	 various	 dairy	 products	 can	 be	
envisaged.	 We	 can	 glean	 from	 the	 numerous	 transgenic	 and	 milk	 protein	 knockout	 studies	
performed	 in	 mice,	 that	 considerable	 changes	 in	 milk	 composition	 can	 be	 tolerated	 without	
interfering	with	micelle	formation.	Therefore,	there	is	considerable	scope	of	the	rational	engineering	
of	milk	for	downstream	processing.		
Most	 studies	 to-date	 with	 regard	 to	 engineering	 milk	 have	 focussed	 on	 known	 genes.	 With	 the	
continuing	reduction	of	genome	sequencing	cost	(Desai	et	al.,	2012),	we	can	anticipate	knowledge	of	
the	 genetic	 variation	 impacting	 on	 milk	 to	 dramatically	 expand.	 To	 illustrate	 the	 potential,	
identification	 of	 the	 genetic	 variation	 controlling	 lactation	 may	 come	 from	 comparison	 of	 the	
underlying	genetics	which	controls	the	extreme	phenotypic	differences	in	milk	production	between	
Bos	 taurus	 and	 Bos	 indicus	 cattle.	 Precision	 breeding	 through	 the	 use	 of	 genome	 editors	 would	
enable	introgression	of	favourable	alleles	(as	is	being	attempted	for	virus	resilience	in	pigs:	(Lillico	et	
al.,	2013).	This	could	have	major	rewards	with	regard	to	Bos	indicus	milk	production	in	the	tropical	
regions	of	the	world.		
There	are	different	ways	 to	utilise	genome	editors.	 The	production	of	 small	 indels	or	mutations	 is	
elegant	in	comparison	to	the	insertion	of	a	transgene,	however	there	may	be	cases	where	the	latter	
is	 preferable.	 It	 has	 become	 apparent	 that	 the	 individual	 animals	 often	 carry	 varying	 numbers	 of	
copies	of	a	gene.	This	is	termed	copy	number	variation	and	may	contribute	to	disease	in	some	cases	
(Clop	 et	 al.,	 2012).	 Analogously,	 the	 casein	 locus	 displays	 an	 ancestral	 copy	 number	 variation	
through	the	duplication	of	the	calcium-sensitive	casein	genes	(Rijnkels	et	al.,	2003)	but	 in	this	case	
the	 extra	 copies	 are	 presumably	 beneficial,	 resulting	 in	 increased	 milk	 protein	 levels.	 Genome	
editing	technology	could	be	deployed	to	continue	this	normal	evolutionary	process	by	enabling	the	
targeted	 integration	 of	 extra	 milk	 protein	 gene	 copies	 into	 the	 genome.	 Targeting	 could	 be	 to	 a	
permissive	 locus,	 equivalent	 to	 the	 mouse	 Rosa	 locus,	 or	 adjacent	 to	 a	 milk	 protein	 gene.	 To	
continue	 this	 theme,	 genome	 editors	 are	 already	 being	 used	 to	 progress	 the	 animal	 bioreactor	
concept	by	enabling	efficient	and	precise	transgene	 integration	(Cui	et	al.,	2015;	Peng	et	al.,	2015;	
Liu	et	al.,	2014a).	
	
The	future	for	engineered	milk		
Food	 security	 for	 all	 is	 an	 ambitious	 challenge,	 yet	 one	 that	 is	 essential	 for	 our	 society	 to	 stably	
migrate	through	the	coming	century.	In	2000,	the	FAO	predicted	that	the	world	will	consume	700m	
tonnes	of	dairy	protein	products	annually	by	2020.	This	 level	of	dairy	production	has	already	been	
reached.	 Can	 we	 expect	 this	 production	 increase	 to	 continue:	 yes,	 if	 the	 industry	 continues	 to	
innovate	and	agriculture	becomes	more	efficient.	Genetic	engineering	technology	can	contribute	to	
this	goal.		
The	next	 few	years	will	 be	exciting	 in	 this	 field.	 For	human	benefit,	 perhaps	 cattle	producing	milk	
without	 the	 major	 allergen	 β-lactoglobulin	 and	 a	 raft	 of	 biomedical	 proteins,	 helping	 to	 treat	
patients,	 produced	 in	 livestock	 milk.	 To	 benefit	 animals	 on	 the	 farm,	 milk	 with	 higher	 levels	 of	
protein	could	be	used	 to	enhance	neonatal	 survival	and	welfare.	This	would	obviously	benefit	 the	
dairy	 industry	 and	 consumer	 alike.	 Alternatively	 we	 can	 consider	 replacing	 the	 endogenous	 milk	
protein	 genes	 of	 livestock	 with	 their	 human	 counterpart	 to	 ‘humanise’	 the	 milk	 for	 human	
consumption.	 As	 scientists	 we	 have	 all	 the	 tools	 we	 need	 to	 achieve	 this	 experimentally.	 The	
challenge	of	translating	these	successes	to	the	farm	and	into	the	food	chain	remains.		
The	 first	 genetically	 engineered	 animal	 to	 navigate	 its	 way	 through	 the	 regulatory	 pathway	 and	
closest	to	entering	our	food	chain	is	the	Aquadvantage	salmonTM	(recently	gaining	FDA	approval	on	
the	19th	November	2015).	In	parallel,	the	European	Food	Safety	Authority	have	published	guidelines	
for	 taking	 a	 GM	 livestock	 product	 through	 to	 market	
(http://www.efsa.europa.eu/en/efsajournal/pub/32iu00).	Others	also	contribute	to	establishing	the	
environment	 for	 this	 to	 happen,	 for	 example	 BIO’s	 good	 stewardship	 guidelines	
(https://www.bio.org/articles/bio-guidance-genetically-engineered-animal-stewardship).	 In	 the	 UK,	
the	 government’s	 Agritech	 strategy	 embraces	 new	 technologies	 including	 genetic	 engineering	
(https://www.gov.uk/government/collections/agricultural-technologies-agri-tech-strategy).	 Similar	
opportunities	 to	 promote	 agriculture	 are	 appearing	 around	 the	 world	 in	 response	 to	 the	 global	
challenge	of	food	security.	The	platform	for	genetically	engineered	livestock	with	enhanced	milk	is	in	
place.	This	 is	not	 to	 imply	 that	 this	 technology	 is	 the	only	way	 forward.	With	 regards	 to	 livestock,	
genetic	selection,	better	husbandry,	optimal	feed	supply,	effective	vaccines	and	available	drugs,	and	
many	other	aspects	will	positively	impact	on	agriculture.	We	can	also	anticipate	significant	advance	
in	dairy	processing,	product	type	and	distribution.	We	will	need	many	solutions	to	provide	enough,	
nutritious	and	safe	food	for	our	societies.		
There	are	counter	activities,	for	example	the	diverse	debate	on	labelling	in	relation	to	GM	foods	in	
the	US.	For	 those	of	us	 in	 the	European	Union,	member	states	can	unilaterally	 choose	 to	ban	GM	
foodstuffs.	Although	this	is	not	based	on	scientific	evidence,	it	could	currently	be	in	the	interest	of	an	
individual	member	state	based	on	political	stances	to	ban	GM	food	production,	 in	the	 longer	term	
such	strategies	run	the	real	risk	of	 ‘second	citizen’	status	for	agriculture	in	those	countries.	Equally	
important	 is	 whether	 the	 citizen	will	 buy	 such	 products	 if	 approved	 and	 on	 the	 shop	 shelf.	 Here	
dialogue	is	needed	to	allow	debate	on	concerns,	risk	and	benefits	to	be	regularly	discussed.	For	this	
to	 be	 successful	 all	 stakeholders	 need	 to	 be	 involved	 and	 each	 must	 come	 with	 an	 open	 mind,	
prepared	to	change	opinion	based	upon	scientific	evidence	and	accept	compromise	as	the	dialogue	
progresses.	For	precision	breeding	using	genome	editing	technology,	this	dialogue	will	complement	
that	which	is	starting	to	consider	the	use	of	these	tools	in	humans	(Lanphier	et	al.,	2015;	Mathews	et	
al.,	2015)	and	that	of	the	non-regulated	random	mutagenic	strategies	which	have	been	widely	used	
for	some	time	in	plant	agriculture	(Schaeffer	&	Nakata,	2015).	
Finally,	we	return	to	our	comment	above,	we	believe	“we	have	all	the	tools”.	It	is	up	to	those	of	us	
who	work	 in	the	field	of	milk	production	to	 imagine	and	experimentally	devise,	 then	transparently	
and	reproducibly	evaluate	what	are	useful	milk-oriented	genetic	engineering	projects.	We	need	to	
robustly	 demonstrate	 the	 utility	 and	 benefit	 to	 both	 animal	 production	 and	 welfare,	 and	 to	 the	
consumer,	and	identify	any	potential	risks.	Then	society	can	choose	to	use	or	not.	
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Figure	1.	A	timeline	of	advances	in	genetic	engineering	of	livestock.		
Figure	2.	Schematic	indicating	how	genome	editing	works.	
Figure	3.	Options	for	engineering	milk.	
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